All In Biotech

Drug Trial Radar · NCT04968158

Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain

Confirmatory Efficacy and Safety Study of the Fixed-dose Combination of Etoricoxib / Tramadol Versus Acetaminophen / Tramadol for the Management of Acute Low Back Pain.

Last checked: Nov 20, 2026Latest source record: Apr 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 124 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

124

Actual

Start

Nov 29, 2021

Primary completion

Mar 15, 2022

Study completion Apr 10, 2022

Sponsor

Sponsor type
Industry
First posted
Jul 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Phase IIIb, longitudinal, multicenter, randomized, open-label clinical trial to evaluate the efficacy and safety of the fixed-dose combination of etoricoxib 90 mg and tramadol 50 mg compared with fixed-dose therapy of acetaminophen 325 mg and tramadol 37.5 mg for the management of acute low back pain.

Conditions

  • Acute Low Back Pain

Interventions

  • Etoricoxib 90 mg / Tramadol 50 mgDrug

    One packet diluted in 100 ml of water, every 24 hours of 90 mg/50 mg.

  • Acetaminophen 325 mg / Tramadol 37.5 mgDrug

    One tablet, every 8 hours of 325 mg/ 37.5 m

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average change in reported painTime frame: Baseline, 3, 5 and 7 days.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Laboratorio Silanes, S.A. de C.V.

    Mexico City, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.